An imbalance in blood collection and demand is anticipated to occur in the near future in Taiwan

Liu, Wenjie; Chen, Yun-Yuan; Hsu, Ling‐I; Chen, Jen-Wei; Wei, Sheng‐Tang; Hou, Sheng‐Mou

doi:10.1016/j.jfma.2021.07.027

Cited by 7 publications

(7 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent studies or reports on Asia give the anticipated challenges to meet future blood supply needs [16][17][18][19]. Indeed, these blood supply challenges are not restricted to Asia but are world-wide [3] and can be compounded by health endemics such as COVID-19.…”

Section: Discussionmentioning

confidence: 99%

Insights into the diversity of blood donation practice across Asia: How blood collection agencies adapt donor criteria and processes to their population

Fung,

Alcantara,

Cavalli

et al. 2023

Vox Sanguinis

View full text Add to dashboard Cite

Background and ObjectivesSecuring an adequate blood supply relies on accurate knowledge of blood donors and donation practices. As published evidence on Asian populations is sparse, this study aims to gather up‐to‐date information on blood donors and donation practices in Asia to assist planning and strategy development.Materials and MethodsTen blood collection agencies (BCAs) provided 12 months' data on donors who met eligibility criteria or were deferred, as well as details of their donation practices. Body mass index and blood volumes were calculated and analysed.ResultsData on 9,599,613 donations and 154,834 deferrals from six national and four regional BCAs revealed varied donation eligibility and collection practices. Seven used haemoglobin (Hb) criteria below the World Health Organization anaemia threshold. Seven accepted donors weighing <50 kg. Data collection on the weight and height of donors and on deferrals was inconsistent, often not routine. Deferred donors appear to weigh less, with corresponding lower estimated blood volume.ConclusionThe diversity in eligibility criteria and donation practices reflects each BCA's strategy for balancing donor health with securing an adequate blood supply. Use of lower Hb criteria substantiate their appropriateness in Asia and indicate the need to define Hb reference intervals relevant to each population. We encourage routine gathering of donor weight and height data to enable blood volume estimation and local optimization of donation volumes. Blood volume estimation formulae specific for the Asian phenotype is needed. Information from this study would be useful for tailoring donation criteria of Asian donors around the world.

show abstract

Section: Discussionmentioning

confidence: 99%

Insights into the diversity of blood donation practice across Asia: How blood collection agencies adapt donor criteria and processes to their population

Fung,

Alcantara,

Cavalli

et al. 2023

Vox Sanguinis

View full text Add to dashboard Cite

show abstract

“… 63 Requests for RBCs are increasing in Taiwan, and authors anticipated that this would endure due to the aging population. 64 In Finland, there is a marked increase in RBC use beginning at around age 50. 65 Those patients age 70 and older have an eightfold higher RBC consumption than their counterparts ages 20–40 years.…”

Section: Recipient-specific Designated or Directed Blood Donationmentioning

confidence: 99%

Patient Blood Management and Its Role in Supporting Blood Supply

Gammon,

Dubey,

Gupta

et al. 2023

JBM

View full text Add to dashboard Cite

Blood donors and voluntary blood donations are essential for ensuring the blood supply that can be maintained by good patient blood management (PBM) practices. This review article explores the role of blood donation in PBM and highlights the importance of donor screening and selection processes in different regions worldwide. The donor health questionnaires and the focused physical examination guidelines have changed in the last decade to increase donor and recipient safety. This article also discusses the status of transfusion practices, including the challenges of ensuring a safe blood supply. Significant among these are the effects of the COVID-19 pandemic on the blood supply chain and the impact of an aging donor population, especially. Promoting autologous donations and other blood conservation strategies are suggested to mitigate these issues. The role of replacement donors and the upper age limit for voluntary blood donation may be decided based on the demography and donor pool. The involvement of C-suite executives is also critical in implementing and running a successful PBM program. The review highlights how these different aspects of blood donation are integral to a successful PBM program and the safety of patients who receive blood transfusions.

show abstract

“…Our goal was to evaluate and determine the most suitable objective index for chronologically monitoring platelet usage and to compare our platelet usage with that of other hospitals. These indices are useful for investigating the outcomes after promoting PBM in hospitals and help respond quickly to the imminent imbalance between the supply and demand of blood products in Taiwan 22 …”

Section: Introductionmentioning

confidence: 99%

“…These indices are useful for investigating the outcomes after promoting PBM in hospitals and help respond quickly to the imminent imbalance between the supply and demand of blood products in Taiwan. 22 …”

Section: Introductionmentioning

confidence: 99%

Objective indexes for comparing platelet usage among peer hospitals during the COVID‐19 pandemic: A cross‐sectional study

Tu,

Hsueh,

Cheng

et al. 2024

Health Science Reports

View full text Add to dashboard Cite

Background and AimsBesides hospital size, clinical diagnosis and severity of patient cases determine the total platelet usage. Therefore, the appropriateness of platelet usage could not be compared simply with the total units of platelet usage in each hospital. This study aimed to objectively monitor and analyze platelet usage after implementing a single‐unit issuing policy for each platelet transfusion in our hospital in October 2020.Materials and MethodsWe used three objective indices, X, Y, and Z, to monitor platelet usage and compared it with other hospitals. Three indices were generated by dividing the annual total units of platelet usage by the total annual reimbursement, total number of admissions, and average total reimbursement per admission for each hospital.ResultsThe new indices X and Y alleviated hospital size–dependent differences. Index Y was preferred over X because its value fluctuated less during the COVID‐19 pandemic. The Z index was adjusted for the average total reimbursement per admission, and the results showed that more patients with higher disease complexity did not have increased platelet usage during the COVID‐19 pandemic. In our hospital (H1), index Z decreased from 2019 to 2021 due to a policy of issuing a single unit for each platelet transfusion.ConclusionThese three objective indices are suitable for peer comparison and monitoring platelet usage in hospitals, irrespective of their size. They could be applied to promote patient blood management and provide an early response to the gradual shortage of blood resources owing to the aging population and declining birth rate in Taiwan.

show abstract

An imbalance in blood collection and demand is anticipated to occur in the near future in Taiwan

Cited by 7 publications

References 13 publications

Insights into the diversity of blood donation practice across Asia: How blood collection agencies adapt donor criteria and processes to their population

Insights into the diversity of blood donation practice across Asia: How blood collection agencies adapt donor criteria and processes to their population

Patient Blood Management and Its Role in Supporting Blood Supply

Objective indexes for comparing platelet usage among peer hospitals during the COVID‐19 pandemic: A cross‐sectional study

Contact Info

Product

Resources

About